MedTrace Logo

LEGO-Based Play Therapy for Children With Autism Spectrum Disorder

NCT07751679 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2026-08-07

No results posted yet for this study

Summary

Autism spectrum disorder (ASD) is a neurodevelopmental condition characterized by difficulties in social communication and interaction, as well as restricted and repetitive patterns of behavior. Children with ASD often experience challenges in developing social relationships and engaging in age-appropriate play activities.

This study aims to evaluate the effectiveness of LEGO®-Based Play Therapy in improving social skills and play skills in children with autism spectrum disorder. Participants are assigned to either a LEGO®-Based Play Therapy group or a control group. The intervention consists of structured group sessions conducted over a 12-week period using collaborative LEGO® building activities designed to promote communication, cooperation, problem-solving, and peer interaction.

The primary outcomes are changes in social skills and play skills measured using validated assessment tools before and after the intervention. The findings of this study may provide evidence regarding the effectiveness of LEGO®-Based Play Therapy as a supportive intervention for children with autism spectrum disorder and contribute to the development of evidence-based psychosocial interventions.

Conditions

Interventions

BEHAVIORAL

LEGO®-Based Play Therapy

Participants receive LEGO®-Based Play Therapy in small groups once weekly for 12 weeks. During each session, children collaboratively build LEGO® models while rotating through three structured roles: Engineer (provides building instructions and guides the task), Supplier (identifies and provides the required LEGO® pieces), and Builder (assembles the LEGO® model according to the instructions). The intervention is designed to improve social communication, cooperation, joint attention, problem-solving, and play skills through structured peer interaction.

Sponsors & Collaborators

  • İstanbul Gedik University

    collaborator UNKNOWN

  • Marmara University

    lead OTHER

Principal Investigators

  • Yeter Çuvadar Baş, MsC · Marmara University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
6 Years
Max Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-08-31
Primary Completion
2026-11-30
Completion
2027-01-31

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07751679 on ClinicalTrials.gov